-
Drugstore owner sentenced to 4 years imprisonment for misdispensing medicines, compensation 1.1 million
Time of Update: 2021-08-15
According to relevant information, the defendant in this case was the owner of a local pharmacy, Qin Moumou, who taught himself to become a doctor since he was a child, and started a Chinese herbal medicine business without formal medical training and without a business license .
-
Etop Pharma's SHP2 allosteric inhibitor approved for clinical trials in China
Time of Update: 2021-08-15
The Center for Drug Evaluation (CDE) of the National Medical Products Administration of China has announced that Etoppharma’s SHP2 allosteric inhibitor ET0038 tablet has obtained two clinical trials implied licenses, and it is planned to be developed for the treatment of advanced solid tumors with abnormal MAPK signaling pathways .
-
Hengrui Medicine: HRS2398 tablets were approved for drug clinical trials
Time of Update: 2021-08-15
have recently received the approval of the State Food and Drug Administration to issue a "Drug Clinical Trial Approval Notice" for HRS2398 tablets, and clinical trials will be launched in the near future.
-
Bayer/Merxton guanylate cyclase agonist approved in the EU for the treatment of heart failure
Time of Update: 2021-08-15
Article Source: Immediate Medicine NewsOn July 21st, Merck (MSD) and Bayer (Bayer) jointly announced that the European Commission (EC) has approved the listing of its soluble guanylate cyclase (sGC) stimulant Verquvo (vericiguat) for the treatment of adults with reduced ejection fraction Patients with symptomatic chronic heart failure who have stabilized after a recent decompensated event that required intravenous (IV) therapy .
-
Drug Evaluation Center of the State Food and Drug Administration: 29 generic drug reference preparations have not passed the review
Time of Update: 2021-08-15
The original text is as follows:Notice on Publicly Soliciting Opinions on the "List of Reference Preparations of Chemical Generic Drugs (Forty-seventh Batch)" (Draft for Solicitation of Comments)According to the "Announcement on the Selection and Determination Procedures for the Publication of Chemical Generic Drug Reference Preparations" issued by the National Bureau on March 28, 2019 (No.
-
When will China Pharmaceuticals release a PDA
Time of Update: 2021-08-15
Is there something like PDA technical report that can be inherited and promoted?And the technological level of the industry is advancing, ha ha .
-
Jiahe Bio-CDK4/6 Inhibitors Approved for Phase 3 Clinical Treatment of Advanced Breast Cancer
Time of Update: 2021-08-15
On July 20th, Jiahe Bio-Bio announced that its GB491 has obtained the National Medical Products Administration (NMPA) clinical trial implied license and approved two phase III clinical trials for breast cancer treatment .
-
Nuotai Bio-Etibatide Injection Obtained Drug Registration Certificate
Time of Update: 2021-08-15
On August 4, Nuotai Biopharmaceuticals announced that it had recently received the "Drug Registration Certificate" (certificate number: 2021S00797) for eptifibatide injection (specification: 10ml:20mg) approved and issued by the State Food and Drug Administration .
-
Biotech BAT6005 injection obtained clinical trial approval
Time of Update: 2021-08-15
TIGIT is an immunoglobulin superfamily protein, which is highly expressed on the surface of activated NK cells, CD4+ T cells, CD8+ T cells and immunosuppressive Tregs .
-
Hengrui Medicine's HR19003 patch was approved for clinical use
Time of Update: 2021-08-15
On August 5, Hengrui Pharmaceuticals issued an announcement stating that the company has recently received the "Notice of Drug Clinical Trial Approval" for the HR19003 patch approved by the National Medical Products Administration, agreeing to use this product for post-herpetic neuralgia.
-
Betta Pharmaceuticals ``Ensatinib'' intends to give priority to the review of the first-line treatment of ALK-positive NSCLC
Time of Update: 2021-08-15
At the WCLC Presidential Symposium in August 2020, the global multicenter phase III clinical (eXalt3) results of Ensatinib for the first-line treatment of ALK-positive NSCLC patients were announced for the first time .
-
mTOR-targeted inhibitors receive FDA priority review qualifications
Time of Update: 2021-08-15
▲Efficacy data of the AMPECT registered trial (picture source: Aadi Bioscience's official website)Note: The original text has been deletedReference materials:[1] Aadi Bioscience Announces FDA Acceptance and Priority Review for the New Drug Application of Fyarro™ for the Treatment of Advanced Malignant PEComa.
Retrieved July 26, 2021, from https:// 07/26/2268451/0/en/Aadi-Bioscience-Announces-FDA-Acceptance-and-Priority-Review-for-the-New-Drug-Application-of-Fyarro-for-the-Treatment-of-Advanced- Malignant-PEComa.
-
Legendary curtain call!
Time of Update: 2021-08-15
Although as a company with annual sales of nearly 100 billion yuan, Yangtze River Pharmaceutical has not yet been listed.
Xu Jingren also revealed that Yangtze River Pharmaceutical will also invest more than 4 billion yuan in Chinese medicine.
-
What is the guidance of the clinical value of drugs to guide the development of anti-tumor drugs?
Time of Update: 2021-08-15
In July this year, China's CDE issued the "Guiding Principles for Clinical Research and Development of Anti-tumor Drugs Oriented by Clinical Value" .
For the first time, this document clearly defines the focus of the clinical value of drugs selected by our country, which are the above six aspects .
-
Leading traditional Chinese medicine has outstanding performance, which raw materials will increase in demand?
Time of Update: 2021-08-14
Analysis of the demand characteristics of Chinese medicinal materials for listed companies in 2021 Through the analysis of the main products and raw materials of the top 10 companies with net profit growth in the first half of the year, our platform found the following rules: First, the demand for raw materials related to the epidemic has increased significantly.
-
Increased squeeze competition?
Time of Update: 2021-08-14
810 ，DTP：，DTP；，，DTP 。，“” 。DTP：，，，？ ，，DTP10， 。DTP，DTP 。 DTPVS DTP！ ，DTP 。、、、，、、 。 According to the definition of the "National Specialty Drug Association" in the US market where the specialty drug market is more developed, DTP pharmacy refers to a national licensed pharmacy that only provides or mainly provides drugs for patients with serious health problems that require complex treatment .
-
Yiling Pharmaceutical: Azithromycin tablets passed the consistency evaluation of generic drugs
Time of Update: 2021-08-14
Acute onset of chronic bronchitis bacterial infection caused by Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae .
Acute otitis media caused by Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae .
Acute bacterial sinusitis caused by Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae .
-
GlaxoSmithKline's chronic hepatitis B treatment drug is planned to be included in breakthrough treatment products
Time of Update: 2021-08-14
The results showed that in patients treated with GSK3228836 at a dose of 300 mg, regardless of whether they had previously received nucleotide analog (NA) treatment, the level of hepatitis B surface antigen (HBsAg) was reduced .
-
Reply from the National Medical Insurance Administration: Accelerate the advancement of traditional Chinese medicine and formula particles into centralized procurement
Time of Update: 2021-08-14
4126 of the Fourth Session of the Thirteenth National People's Congress, and responded to the receipt of the recommendation made by Representative Lu Qingguo on accelerating the entry of traditional Chinese medicine and formula granules into centralized procurement .
-
The semi-annual reports of a number of multinational pharmaceutical companies disclose that these 10 drugs are the best sellers
Time of Update: 2021-08-14
6 billion, an increase of 42% year-on-year, of which the first quarter sales revenue of BTN162b2 reached US$3.
Moderna's 2021 second-quarter performance report shows that the number of mRNA-1273 new crown vaccines sold reached 199 million doses, and sales reached 4.
